Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8382267rdf:typepubmed:Citationlld:pubmed
pubmed-article:8382267lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:8382267lifeskim:mentionsumls-concept:C0003241lld:lifeskim
pubmed-article:8382267lifeskim:mentionsumls-concept:C1823153lld:lifeskim
pubmed-article:8382267lifeskim:mentionsumls-concept:C2349976lld:lifeskim
pubmed-article:8382267lifeskim:mentionsumls-concept:C1552644lld:lifeskim
pubmed-article:8382267lifeskim:mentionsumls-concept:C1711351lld:lifeskim
pubmed-article:8382267lifeskim:mentionsumls-concept:C0205923lld:lifeskim
pubmed-article:8382267pubmed:issue3lld:pubmed
pubmed-article:8382267pubmed:dateCreated1993-3-24lld:pubmed
pubmed-article:8382267pubmed:abstractTextA gamma-aminobutyric acidA (GABAA) receptor (GABAAR) gamma 2 subunit (short form) was cloned from an adult human cerebral cortex cDNA library in bacteriophage lambda gt11. The 261-bp intracellular loop (IL) located between M3 and M4 was amplified using the polymerase chain reaction and inserted into the expression vectors lambda gt11 and pGEX-3X. Both beta-galactosidase (LacZ) and glutathione-S-transferase (GST) fusion proteins containing the gamma 2IL were purified, and a rabbit antibody to the LacZ-gamma 2IL was made. The antibody reacted with the gamma 2IL of both LacZ and GST fusion proteins and immunoprecipitated the GABAAR/benzodiazepine receptor (GABAAR/BZDR) from bovine and rat brain. The antibody reacted in affinity-purified GABAAR/BZDR immunoblots with a wide peptide band of 44,000-49,000 M(r). Immunoprecipitation studies with the anti-gamma 2IL antibody suggest that in the cerebral cortex, 87% of the GABAARs with high affinity for benzodiazepines and 70% of the GABAARs with high affinity for muscimol contain at least a gamma subunit, probably a gamma 2. These results indicate that there are [3H]muscimol binding GABAARs that do not bind [3H]flunitrazepam with high affinity. Immunoprecipitations with this and other anti-GABAAR/BZDR antibodies indicate that the most abundant combination of GABAAR subunits in the cerebral cortex involves alpha 1, gamma 2 (or other gamma), and beta 2 and/or beta 3 subunits. These subunits coexist in > 60% of the GABAAR/BZDRs in the cerebral cortex. The results also show that a considerable proportion (20-25%) of the cerebellar GABAAR/BZDRs is clonazepam insensitive. At least 74% of these cerebellar receptors, which likely contain alpha 6, also contain gamma 2 (or other gamma) subunit(s). The alpha 1 and beta 2 or beta 3 subunits are also frequently associated with gamma 2 (or other gamma) and alpha 6 in these cerebellar receptors.lld:pubmed
pubmed-article:8382267pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8382267pubmed:languageenglld:pubmed
pubmed-article:8382267pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8382267pubmed:citationSubsetIMlld:pubmed
pubmed-article:8382267pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8382267pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8382267pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8382267pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8382267pubmed:statusMEDLINElld:pubmed
pubmed-article:8382267pubmed:monthMarlld:pubmed
pubmed-article:8382267pubmed:issn0022-3042lld:pubmed
pubmed-article:8382267pubmed:authorpubmed-author:FernandoL PLPlld:pubmed
pubmed-article:8382267pubmed:authorpubmed-author:MalletJJlld:pubmed
pubmed-article:8382267pubmed:authorpubmed-author:KhanZ UZUlld:pubmed
pubmed-article:8382267pubmed:authorpubmed-author:De BlasA LALlld:pubmed
pubmed-article:8382267pubmed:authorpubmed-author:BusquetsXXlld:pubmed
pubmed-article:8382267pubmed:authorpubmed-author:MirallesC PCPlld:pubmed
pubmed-article:8382267pubmed:authorpubmed-author:EscribáPPlld:pubmed
pubmed-article:8382267pubmed:authorpubmed-author:FillaMMlld:pubmed
pubmed-article:8382267pubmed:issnTypePrintlld:pubmed
pubmed-article:8382267pubmed:volume60lld:pubmed
pubmed-article:8382267pubmed:ownerNLMlld:pubmed
pubmed-article:8382267pubmed:authorsCompleteYlld:pubmed
pubmed-article:8382267pubmed:pagination961-71lld:pubmed
pubmed-article:8382267pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:8382267pubmed:meshHeadingpubmed-meshheading:8382267-...lld:pubmed
pubmed-article:8382267pubmed:meshHeadingpubmed-meshheading:8382267-...lld:pubmed
pubmed-article:8382267pubmed:meshHeadingpubmed-meshheading:8382267-...lld:pubmed
pubmed-article:8382267pubmed:meshHeadingpubmed-meshheading:8382267-...lld:pubmed
pubmed-article:8382267pubmed:meshHeadingpubmed-meshheading:8382267-...lld:pubmed
pubmed-article:8382267pubmed:meshHeadingpubmed-meshheading:8382267-...lld:pubmed
pubmed-article:8382267pubmed:meshHeadingpubmed-meshheading:8382267-...lld:pubmed
pubmed-article:8382267pubmed:meshHeadingpubmed-meshheading:8382267-...lld:pubmed
pubmed-article:8382267pubmed:meshHeadingpubmed-meshheading:8382267-...lld:pubmed
pubmed-article:8382267pubmed:meshHeadingpubmed-meshheading:8382267-...lld:pubmed
pubmed-article:8382267pubmed:year1993lld:pubmed
pubmed-article:8382267pubmed:articleTitleAntibodies to the human gamma 2 subunit of the gamma-aminobutyric acidA/benzodiazepine receptor.lld:pubmed
pubmed-article:8382267pubmed:affiliationDivision of Molecular Biology and Biochemistry, School of Biological Sciences, University of Missouri, Kansas City 64110-2499.lld:pubmed
pubmed-article:8382267pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8382267pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8382267lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8382267lld:pubmed